To print this article, all you need is to be registered or login on Mondaq.com.
Last year, New South Wales Corrective Services injected about 900 prison inmates a month with a view to keeping them away from illegal drugs.
Injecting inmates with an opioid called Buprenorphine, or ‘Bupe , is intended to help inmates who have a dependency on heroin and other opioids – such as codeine, fentanyl, morphine and methadone.
The initiative follows a ‘successful clinical trial by the Justice Health and Forensic Mental Health Network.
Prison officer detained
But the well-meaning programme has had unintended consequences, with reports of inmates threatening and even assaulting prison staff to gain access to the drug.
To print this article, all you need is to be registered or login on Mondaq.com.
In order to encourage the development of innovative
pharmaceutical companies in China, patent term extension (PTE) is
introduced for the first time to the amended Chinese Patent Law
that will take effect from June 1, 2021.
PTE was first introduced from the Hatch-Waxman act of the U.S in
1984, with the aim to make up for the time taken for the clinical
trials and market approval of a drug. At the beginning of 2020, PTE
was mentioned in the Economic and Trade Agreement Between China and
the U.S, and then was added to Article 42 of the new Chinese Patent
To print this article, all you need is to be registered or login on Mondaq.com.
The Slovak Advertising Standards Council (SRPR) assessed the
food chamber s complaint against a series of Christmas
advertisements of the retail chain Lidl for affordable foods.
Satisfied customers who come out of Lidl s shops with shopping
bags so full that the purchased food almost drops out of them
appear in the advertising spots.
The Slovak Food Chamber perceived these spots as outrageous and
unethical. According to the chamber, we do not produce food so that
it then falls out of the customers´ kitchen cabinets. The
To print this article, all you need is to be registered or login on Mondaq.com.
In 2019, the CJEU clarified the EU s position on
compensation for wrongly restrained defendants in IP enforcement
proceedings. What are the implications of this decision and how
does it compare with recent trends in England and
Australia?
Provisional measures in intellectual property enforcement and,
in particular, patent enforcement in the pharmaceutical industry,
have always required a careful balancing act between the interests
of the rights-holder and the interests of the alleged
infringer.
This is because, at an early stage in proceedings, the court is
required to consider restraining an alleged infringer from certain
CSPs).
(a) COVID-19
In response to the COVID-19 pandemic, the federal government
pursued Interim Orders and other policy changes intended to
expedite the development of COVID-19-related products, including
drugs, vaccines, hand sanitizers, disinfectants, personal
protective equipment, and medical devices (see
e.g., here and here). Both the federal and provincial
governments made regulatory changes to secure domestic drug
supplies and mitigate shortages (see
e.g., here and here). Many of these policies were passed on
an interim basis but still remain in effect.
Patent Act, adding a
provision that allowed the Minister of Health to apply for
authorization to make, construct, use, and sell a patented